Orbimed Advisors - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 32 filers reported holding SCPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$39,583,839
-30.1%
5,559,5280.0%0.84%
-18.0%
Q2 2023$56,651,590
+12.3%
5,559,5280.0%1.03%
+3.6%
Q1 2023$50,424,919
+26.5%
5,559,5280.0%0.99%
+29.8%
Q4 2022$39,861,816
+27.4%
5,559,528
+15.9%
0.76%
+31.3%
Q3 2022$31,277,000
+35.3%
4,797,1480.0%0.58%
+38.7%
Q2 2022$23,122,000
-15.1%
4,797,1480.0%0.42%
-5.2%
Q1 2022$27,248,000
+13.1%
4,797,1480.0%0.44%
+42.6%
Q4 2021$24,082,000
-24.5%
4,797,1480.0%0.31%
-11.7%
Q3 2021$31,901,000
+8.8%
4,797,1480.0%0.35%
+18.6%
Q2 2021$29,311,000
-8.1%
4,797,1480.0%0.30%
-0.7%
Q1 2021$31,901,000
+25.7%
4,797,1480.0%0.30%
+34.2%
Q4 2020$25,377,000
-29.0%
4,797,1480.0%0.22%
-50.6%
Q3 2020$35,739,000
+1.2%
4,797,1480.0%0.45%
-9.7%
Q2 2020$35,307,000
+39.9%
4,797,148
+40.7%
0.50%
+17.2%
Q1 2020$25,233,000
+30.7%
3,409,8650.0%0.42%
+53.6%
Q4 2019$19,300,000
-3.6%
3,409,8650.0%0.28%
-27.4%
Q3 2019$20,016,000
+84.0%
3,409,8650.0%0.38%
+126.2%
Q2 2019$10,877,000
+6.3%
3,409,8650.0%0.17%
+6.3%
Q1 2019$10,230,000
-20.2%
3,409,8650.0%0.16%
-33.3%
Q4 2018$12,821,000
-35.9%
3,409,8650.0%0.24%
-1.7%
Q3 2018$20,016,000
+3.7%
3,409,8650.0%0.24%
+4.8%
Q2 2018$19,300,000
-54.4%
3,409,8650.0%0.23%
-56.1%
Q1 2018$42,282,000
+2.6%
3,409,8650.0%0.52%
+0.6%
Q4 2017$41,225,0003,409,8650.52%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,561,474$17,166,0004.25%
AIGH Capital Management LLC 1,346,724$6,491,0001.71%
Worth Venture Partners, LLC 335,985$1,784,0001.05%
Ikarian Capital, LLC 884,008$4,261,0000.78%
Orbimed Advisors 4,797,148$23,122,0000.42%
ARMISTICE CAPITAL, LLC 2,700,000$13,014,0000.23%
Sandy Cove Advisors, LLC 10,592$51,0000.05%
Belvedere Trading LLC 239,219$1,270,0000.04%
IPG Investment Advisors LLC 14,300$69,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,200$637,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders